Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Nasal Insulin Expands Trial for Postpranidal Hyperglycemia Indication Posted: Thursday, December 07, 2006

Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley's human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.

Exubera Slow to Catch On Posted: Thursday, December 07, 2006

Jury is still out on Exubera. Diabetics are holding their breath, and that may not be good news for the Pfizer, the world's biggest drugmaker. It's been nearly a year since the FDA approved Exubera, the first inhalable form of insulin for diabetics. Some analysts hail the device as a potential blockbuster, but Exubera doesn't appear to have caught on.

Nasal Insulin Spray Moving Forward with Phase 2 Trials Posted: Thursday, November 30, 2006

Two earlier studies conducted in Ireland with normal subjects and Type I diabetic patients demonstrated rapid absorption from the nasal spray and the expected glucose response.

Insulin Pump Therapy for Adolescents is More Effective with Proper Training Posted: Thursday, November 09, 2006

Researchers have shown that when adolescents are checking their blood sugars 4 to 5 time a day prior to going on the pump, that more than 80% of adolescents will continue with pump therapy and improve their outcomes.

Inhalable Insulin May Be A ‘Flop' Posted: Thursday, November 02, 2006

Inhalable insulin is unlikely to achieve the blockbuster status the industry had hoped for, according to a new report.

Switch To Insulin Pen Improves Clinical Outcomes And Reduces Medical Costs Posted: Thursday, November 02, 2006

Total all-cause annual treatment costs reduced by $1590 per patient.

Preoperative Hyperglycemia Imperils Orthopedic Surgery Outcome Posted: Wednesday, October 25, 2006

Study finds a sixfold higher threat of pulmonary embolism after hip or knee replacements.

Unlimited Supply of Beta Cells Found Posted: Wednesday, October 25, 2006

Diabetes in Control interviewed Novocells’ Chief Scientific Officer, Emmanual Baetge and he told us that they have determined the necessary conditions for turning human embryonic stem cells into insulin-producing cells, a finding that moves the prospect of using these cells to treat diabetes closer to the clinic.

Pac Man Like Enzyme Key to New Diabetes Drug Posted: Thursday, October 19, 2006

Scientists have deciphered the structure of a "Pac Man"-like enzyme that could form the basis of new treatments for diabetes and Alzheimer's disease.

Roche Diagnostics Announces Launch of ACCU-CHEK® Spirit Insulin Pump System Posted: Thursday, October 19, 2006

New system provides more options for insulin pump users.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.